We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

230 hedge funds and large institutions have $1.96B invested in Arena Pharmaceuticals Inc in 2019 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 83 increasing their positions, 58 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 25

43% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 58

7% more funds holding

Funds holding: 215 → 230 (+15)

21% less capital invested

Capital invested by funds: $2.47B → $1.96B (-$506M)

28% less call options, than puts

Call options by funds: $12M | Put options by funds: $16.7M

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
230
Holders Change
+15
Holders Change %
+6.98%
% of All Funds
5.04%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
40
Increased
83
Reduced
58
Closed
25
Calls
$12M
Puts
$16.7M
Net Calls
-$4.73M
Net Calls Change
-$7.79M

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$24.9M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$16.7M
3
State Street
State Street
Massachusetts
+$14.8M
4
Marshall Wace
Marshall Wace
United Kingdom
+$12.5M
5
APG Asset Management
APG Asset Management
Netherlands
+$12.5M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$46.5M
2
PA
Perceptive Advisors
New York
-$24M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$11.2M
4
Primecap Management
Primecap Management
California
-$8.95M
5
EMG
ETF Managers Group
New Jersey
-$8.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCA
201
Stonebridge Capital Advisors
Minnesota
$21K – – –
LC
202
Lindbrook Capital
California
$16K – – –
Walleye Trading
203
Walleye Trading
New York
$15K -$393 -7 -2%
NCM
204
Northstar Capital Management
New York
$15K – – –
BFEC
205
Benjamin F. Edwards & Company
Missouri
$14K – – –
Daiwa Securities Group
206
Daiwa Securities Group
Japan
$14K – – –
TCOV
207
Trust Company of Vermont
Vermont
$14K +$16.9K +300 New
CSS
208
Cubist Systematic Strategies
Connecticut
$10K +$6.07K +108 +108%
US Bancorp
209
US Bancorp
Minnesota
$10K +$10.7K +190 +792%
WEC
210
Winslow Evans & Crocker
Massachusetts
$8K +$4.83K +86 +123%
SFS
211
Sowell Financial Services
Arkansas
$8K +$9.84K +175 New
Twin Tree Management
212
Twin Tree Management
Texas
$6K +$7.36K +131 New
PMFA
213
Plante Moran Financial Advisors
Michigan
$5K – – –
NFG
214
Next Financial Group
Texas
$3K – – –
RE
215
RBC Europe
United Kingdom
$2.98K – – –
CAPTRUST Financial Advisors
216
CAPTRUST Financial Advisors
North Carolina
$2K -$2.25K -40 -50%
APC
217
Aspire Private Capital
North Carolina
$2K – – –
IFAM
218
Institutional & Family Asset Management
Colorado
$2K – – –
BCA
219
Berman Capital Advisors
Georgia
$1K – – –
GSWM
220
Golden State Wealth Management
California
$1K – – –
HAM
221
Highstreet Asset Management
Ontario, Canada
$1K – – –
TFS
222
TrustCore Financial Services
Tennessee
$1K – – –
VCM
223
Versant Capital Management
Arizona
$1K – – –
MCM
224
MV Capital Management
Maryland
$1K +$1.01K +18 New
PCG
225
Private Capital Group
Connecticut
$1K +$1.24K +22 New
7 8
9
10 11

ARNA Hedge Fund Activity: Q3 2019 in Review

230 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2019, worth a combined $1.96B — down 21% from $2.47B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new ARNA positions and 25 closed out — a net gain of 15 holders — while 83 added to existing stakes and 58 trimmed.

The largest buyer was PFM Health Sciences, adding an estimated $24.9M. The largest seller was Fidelity Investments, cutting an estimated $46.5M.

  • 230 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2019, up from 215 in Q2 2019.
  • Funds reported $1.96B of Arena Pharmaceuticals Inc stock for Q3 2019, down 21% quarter-over-quarter.
  • 40 funds opened new Arena Pharmaceuticals Inc positions in Q3 2019 and 25 closed out, a net change of +15 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2019 was PFM Health Sciences, an estimated $24.9M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2019 was Fidelity Investments, an estimated $46.5M sold.

Based on aggregated 13F filings for Q3 2019.